- Home
- BCTX vs EBON Comparison
BCTX vs EBON Comparison
Compare BCTX & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- EBON
- Stock Information
- Founded
- BCTX 2014
- EBON 2010
- Country
- BCTX Canada
- EBON China
- Employees
- BCTX N/A
- EBON N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- EBON Semiconductors
- Sector
- BCTX Health Care
- EBON Technology
- Exchange
- BCTX Nasdaq
- EBON Nasdaq
- Market Cap
- BCTX 21.8M
- EBON 24.4M
- IPO Year
- BCTX N/A
- EBON 2020
- Fundamental
- Price
- BCTX $11.85
- EBON $4.53
- Analyst Decision
- BCTX Strong Buy
- EBON
- Analyst Count
- BCTX 1
- EBON 0
- Target Price
- BCTX $40.00
- EBON N/A
- AVG Volume (30 Days)
- BCTX 78.8K
- EBON 20.6K
- Earning Date
- BCTX 10-27-2025
- EBON 08-15-2025
- Dividend Yield
- BCTX N/A
- EBON N/A
- EPS Growth
- BCTX N/A
- EBON N/A
- EPS
- BCTX N/A
- EBON N/A
- Revenue
- BCTX N/A
- EBON $7,337,066.00
- Revenue This Year
- BCTX N/A
- EBON N/A
- Revenue Next Year
- BCTX $380.95
- EBON N/A
- P/E Ratio
- BCTX N/A
- EBON N/A
- Revenue Growth
- BCTX N/A
- EBON 104.28
- 52 Week Low
- BCTX $6.00
- EBON $3.00
- 52 Week High
- BCTX $190.50
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- BCTX 62.04
- EBON 47.43
- Support Level
- BCTX $10.76
- EBON $4.25
- Resistance Level
- BCTX $12.76
- EBON $5.09
- Average True Range (ATR)
- BCTX 0.77
- EBON 0.52
- MACD
- BCTX -0.30
- EBON -0.06
- Stochastic Oscillator
- BCTX 39.25
- EBON 16.97
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.